lynparza prostate cancer

Lynparza, also known as olaparib, is a medication used for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults. It is a PARP inhibitor that works by inhibiting poly ADP ribose polymerase, an enzyme involved in DNA repair